Cogent Biosciences Inc (COGT) Event Aug. 09, 2022, 00:00 UTC (75% Positive) Cogent Biosciences, Inc. (COGT) Reports 57% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 7:05 p.m. 🏢 Cogent Biosciences Inc (COGT) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-09 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-28.28M $-65.56M $37.28M +56.87% 📉 Total Assets $232.09M $366.05M $-133.96M -36.60% 📉 Total Liabilities $17.91M $46.67M $-28.76M -61.63% 📈 Stockholders' Equity $212.80M $-226.98M $439.78M +193.76% 📈 Operating Income/Loss $-30.09M $-67.27M $37.18M +55.27% 📉 R&D Expense $20.60M $54.95M $-34.35M -62.51% 📈 Earningspersharebasic $-0.77 $-1.39 $0.62 +44.60% 📈 Earningspersharediluted $-0.77 $-1.39 $0.62 +44.60% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Cogent Biosciences Inc (COGT) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document